For a broader overview, see my GLP-1 diet plan guide
Testosterones cardiac reputation, for years the big fear, mostly held up to scrutiny: in a trial of more than 5,000 men at high cardiovascular risk, TRT did not cause more heart attacks than placebo (Lincoff, New England Journal of Medicine, 2023)
Patients should consult their prescribing physician, endocrinologist, or licensed pharmacist before selecting a needle gauge, barrel volume, or injection technique
Pharmaceutical Manufacturers The primary defendants in GLP-1 lawsuits are typically the drug manufacturers who may be liable for: Failing to conduct adequate safety testing before bringing the drug to market Withholding information about known risks from the FDA, doctors, and patients Not updating warning labels despite mounting evidence of serious complications Prioritizing profits over patient safety Engaging in aggressive marketing that downplayed potential dangers Healthcare Providers In some cases, doctors or medical facilities may share liability if they: Failed to properly screen patients for risk factors Prescribed the medication for off-label uses without adequate warnings Ignored symptoms that suggested developing complications Did not order appropriate diagnostic tests when warning signs appeared Continued prescribing despite clear contraindications Distributors and Pharmacies Companies involved in distributing or dispensing GLP-1 medications might be liable if they: Failed to provide the required safety information to patients Distributed medications without proper storage or handling Dispensed drugs obtained from unauthorized or unsafe sources Our attorneys thoroughly investigate your case to identify all responsible parties and hold them accountable for your injuries
Thymosin 4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
Nat Rev Nephrol (2011) 7(6):32740
